VC
Visalakshi Chandramouli
About Visalakshi Chandramouli
Data last updated:
Visalakshi Chandramouli is a Director at Cellcure Cancer Centre Private Limited (since 2025), Director at Linux Laboratories Private Limited (since 2021) and Nominee Director at Orbicular Pharmaceutical Technologies Private Limited (since 2024), and holds 5 more current directorships. The companies operate in Healthcare, Pharma and Information Technology. The 8 current companies with reported revenue have a combined latest revenue of ₹1,544 Cr; the largest is Cellcure Cancer Centre Private Limited at ₹335 Cr (FY 2025). Earlier, Visalakshi Chandramouli was a Director at Sai Life Sciences Limited (2016–2018) and Nominee Director at Konverge Healthcare Private Limited (2017–2020) and 4 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Cellcure Cancer Centre Private Limited U74999MH2017PTC301138 | Director | 29 Nov 2025 | 2017 | ₹335 Cr (FY 2025) | Active |
 Linux Laboratories Private Limited U24232TN2011PTC082443 | Director | 23 Feb 2021 | 2011 | ₹285 Cr (FY 2025) | Active |
 Orbicular Pharmaceutical Technologies Private Limited U24233TG2008PTC060606 | Nominee Director | 31 May 2024 | 2008 | ₹272 Cr (FY 2025) | Active |
 Brinton Pharmaceuticals Limited U24232PN2013PLC148971 | Nominee Director | 30 Mar 2017 | 2013 | ₹215 Cr (FY 2025) | Active |
 Anderson Diagnostic Services Private Limited U85100TN2011PTC082643 | Nominee Director | 08 Jun 2022 | 2011 | ₹204 Cr (FY 2025) | Active |
 Sakar Healthcare Limited L24231GJ2004PLC043861 | Director | 01 Sep 2023 | 2004 | ₹179 Cr (FY 2025) | Active |
 Deeptek Medical Imaging Private Limited U74999PN2018FTC177289 | Nominee Director | 02 Mar 2022 | 2018 | ₹35.14 Cr (FY 2025) | Active |
| Brinton Healthcare Limited U24297PN2019PLC187750 | Nominee Director | 03 Mar 2020 | 2019 | ₹18.82 Cr (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sai Life Sciences Limited L24110TG1999PLC030970 | Director | 18 Jan 2016 | 1999 | ₹1,731 Cr (FY 2025) | Active |
 Konverge Healthcare Private Limited U24232KA2014PTC077624 | Nominee Director | 31 Mar 2017 | 2014 | ₹10.11 Cr (FY 2020) | Under Cirp |
 Novalead Pharma Private Limited U73100PN2007PTC130929 | Nominee Director | 30 Sep 2011 | 2007 | ₹16.4 Lakh (FY 2024) | Active |
 Fresenius Medical Care Dialysis Services India Private Limited U85100DL2011PTC419821 | Director | 08 Mar 2014 | 2011 | ₹37.49 Cr (FY 2023) | Active |
 Lokmanya Hospitals Private Limited U85190PN2009PTC134052 | Director | 18 Mar 2014 | 2009 | ₹117 Cr (FY 2025) | Active |
| Deeptek Medical Services Private Limited U74900PN2008PTC132898 | Nominee Director | 02 Mar 2022 | 2008 | ₹14.76 Cr (FY 2024) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Visalakshi Chandramouli
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Visalakshi Chandramouli
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Visalakshi Chandramouli
Visalakshi Chandramouli currently holds 8 directorships: Cellcure Cancer Centre Private Limited (Director, since 29 Nov 2025, revenue ₹335 Cr (FY 2025)); Linux Laboratories Private Limited (Director, since 23 Feb 2021, revenue ₹285 Cr (FY 2025)); Orbicular Pharmaceutical Technologies Private Limited (Nominee Director, since 31 May 2024, revenue ₹272 Cr (FY 2025)); Brinton Pharmaceuticals Limited (Nominee Director, since 30 Mar 2017, revenue ₹215 Cr (FY 2025)); Anderson Diagnostic Services Private Limited (Nominee Director, since 08 Jun 2022, revenue ₹204 Cr (FY 2025)); and 3 more.
Visalakshi Chandramouli was first appointed on 30 Sep 2011 as Nominee Director at Novalead Pharma Private Limited. The most recent appointment on record is 29 Nov 2025 at Cellcure Cancer Centre Private Limited.
The 8 current companies of Visalakshi Chandramouli that report revenue have a combined latest revenue of ₹1,544 Cr: Cellcure Cancer Centre Private Limited ₹335 Cr (FY 2025); Linux Laboratories Private Limited ₹285 Cr (FY 2025); Orbicular Pharmaceutical Technologies Private Limited ₹272 Cr (FY 2025); Brinton Pharmaceuticals Limited ₹215 Cr (FY 2025); Anderson Diagnostic Services Private Limited ₹204 Cr (FY 2025); and 3 more.
Visalakshi Chandramouli held 6 earlier board appointments: Sai Life Sciences Limited (Director, 18 Jan 2016 to 25 Jul 2018); Konverge Healthcare Private Limited (Nominee Director, 31 Mar 2017 to 26 Oct 2020); Novalead Pharma Private Limited (Nominee Director, 30 Sep 2011 to 15 Sep 2021); Fresenius Medical Care Dialysis Services India Private Limited (Director, 08 Mar 2014 to 15 Sep 2016); Lokmanya Hospitals Private Limited (Director, 18 Mar 2014 to 05 Jul 2024); and 1 more.
The current boards of Visalakshi Chandramouli's companies include Ashish Anand Joshi (Cellcure Cancer Centre Private Limited), Bhavin Ashokbhai Shah (Cellcure Cancer Centre Private Limited), Kshitij Chandrakant Joshi (Cellcure Cancer Centre Private Limited), Mayank Khanduja (Cellcure Cancer Centre Private Limited), Preetam Baban Kalaskar (Cellcure Cancer Centre Private Limited), Vashista Pankaj Maniar (Cellcure Cancer Centre Private Limited), among others.